In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana

Hepatitis B virus (HBV) is the primary cause of liver-related malignancies worldwide, and there is no effective cure for chronic HBV infection (CHB) currently. Strong immunological responses induced by T cells are associated with HBV clearance during acute infection; however, the repertoire of epito...

Full description

Bibliographic Details
Main Authors: Wonderful Tatenda Choga, Motswedi Anderson, Edward Zumbika, Bonolo B. Phinius, Tshepiso Mbangiwa, Lynnette N. Bhebhe, Kabo Baruti, Peter Opiyo Kimathi, Kaelo K. Seatla, Rosemary M. Musonda, Trevor Graham Bell, Sikhulile Moyo, Jason T. Blackard, Simani Gaseitsiwe
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Viruses
Subjects:
hepatitis B virus (HBV)
HLA class II alleles
T-cell epitopes
in silico
immunoinformatics
candidate multi-epitope vaccines (MEV)
Online Access:https://www.mdpi.com/1999-4915/12/7/731

Similar Items

Similar Items